CryoBioPhysica, Inc. Appoints Jeff Conroy to Board of Directors

Rockville, MD. CryoBioPhysica, Inc., a biotechnology company focused on novel protein separation technologies for ion chromatography, has named Jeff Conroy as a Director of the corporation. Jeff Conroy is the CEO of Adjuvant, a strategic transaction advisory firm, and Managing Director of Windward Investments.

“Adjuvant has provided valuable operational and transaction advisory services to our company for some time. We have appointed Jeff to the Board to leverage his operational and financial expertise as we execute our growth and alliance priorities”, said Harold T. Meryman, MD, Chairman and CEO of CryoBioPhysica. “As we continue to establish our pISep platform for ion chromatography, we look forward to Jeff’s leadership and contribution to achieving our imperatives”, said Meryman.

“The pISep platform offers sensitivity and control which greatly expands the ability of scientists to identify proteins and control production, particularly in monoclonal antibodies and peptides”, said Conroy. “I am committed to advancing pISep as we grow our customer base, strengthen strategic alliances, and secure growth capital”, he continued.

CryoBioPhysica, Inc. has developed pISep, an advance platform for protein separation utilizing ion exchange chromatography. The pISep software and buffer set enables complete control of externally generated pH gradients from pH 2 to 12 in the presence of all major brands of both cationic and anionic exchange resins.

Adjuvant, Inc. is a strategic transaction advisory firm focused on the life science market. The Adjuvant BIOdB (ww.biodb.com) is our global database of the alliance and licensing priorities of over 2,500 biotechnology and pharmaceutical companies. For Inquiries, please Contact Chris Robson at 703-266-2740 or visit www.adjuvant.com .